Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial

BACKGROUND: Treatment of recurrent glioblastoma (GBM) remains problematic with survival after additional therapy typically less than 12 months. We prospectively evaluated whether outcomes might be improved with resection plus permanent implantation of a novel radiation device utilizing the gamma-emi...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Kris, Nakaji, Peter, Thomas, Theresa, Pinnaduwage, Dilini, Wallstrom, Garrick, Choi, Mehee, Zabramski, Joseph, Chen, Clark, Brachman, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629483/
https://www.ncbi.nlm.nih.gov/pubmed/36322102
http://dx.doi.org/10.1093/neuonc/noac133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629483/
https://www.ncbi.nlm.nih.gov/pubmed/36322102
http://dx.doi.org/10.1093/neuonc/noac133

Ejemplares similares